CNBX Pharmaceuticals Inc. Quarterly Common Stock, Shares, Outstanding from Q3 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
CNBX Pharmaceuticals Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q3 2013 to Q2 2024.
  • CNBX Pharmaceuticals Inc. Common Stock, Shares, Outstanding for the quarter ending May 31, 2024 was 3.11M shares, a 80.6% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 3.11M -12.9M -80.6% May 31, 2024 10-Q 2024-07-15
Q1 2024 3.11M +902K +40.8% Feb 29, 2024 10-Q 2024-04-16
Q4 2023 28.3M +27.1M +2151% Nov 30, 2023 10-Q 2024-01-12
Q3 2023 22.6M +21.4M +1725% Aug 31, 2023 10-Q 2024-07-15
Q2 2023 16M +14.8M +1194% May 31, 2023 10-Q 2023-07-14
Q1 2023 2.21M -147M -98.5% Feb 28, 2023 10-Q 2023-04-14
Q4 2022 1.26M -147M -99.2% Nov 30, 2022 10-Q 2023-01-13
Q3 2022 1.24M -147M -99.2% Aug 31, 2022 10-K 2023-11-30
Q2 2022 1.24M -141M -99.1% May 31, 2022 10-Q 2022-07-14
Q1 2022 149M +14.2M +10.5% Feb 28, 2022 10-Q 2022-04-12
Q4 2021 149M +13.4M +9.93% Nov 30, 2021 10-Q 2022-01-13
Q3 2021 149M +13.6M +10.1% Aug 31, 2021 10-K 2022-11-30
Q2 2021 143M +7.5M +5.55% May 31, 2021 10-Q 2021-07-14
Q1 2021 135M +202K +0.15% Feb 28, 2021 10-Q 2021-04-14
Q4 2020 135M +819K +0.61% Nov 30, 2020 10-Q 2021-01-14
Q3 2020 135M +582K +0.43% Aug 31, 2020 10-K 2021-11-29
Q2 2020 135M +622K +0.46% May 31, 2020 10-Q 2020-07-14
Q1 2020 135M +2.84M +2.15% Feb 29, 2020 10-Q 2020-04-13
Q4 2019 134M +2.59M +1.96% Nov 30, 2019 10-Q 2020-01-14
Q3 2019 134M +12.9M +10.6% Aug 31, 2019 10-K 2020-11-04
Q2 2019 134M +13.6M +11.3% May 31, 2019 10-Q 2019-07-15
Q1 2019 132M +11.7M +9.72% Feb 28, 2019 10-Q 2019-04-15
Q4 2018 132M +12.3M +10.3% Nov 30, 2018 10-Q 2019-01-17
Q3 2018 122M +2.03M +1.7% Aug 31, 2018 10-K 2019-11-29
Q2 2018 121M +2.5M +2.11% May 31, 2018 10-Q 2018-07-16
Q1 2018 120M +5.81M +5.07% Feb 28, 2018 10-Q 2018-04-05
Q4 2017 120M +5.49M +4.81% Nov 30, 2017 10-Q 2018-01-16
Q3 2017 120M +12.3M +11.5% Aug 31, 2017 10-K 2018-11-29
Q2 2017 118M +11.3M +10.6% May 31, 2017 10-Q 2017-07-17
Q1 2017 115M +12M +11.7% Feb 28, 2017 10-Q 2017-04-14
Q4 2016 114M +11.9M +11.7% Nov 30, 2016 10-Q 2017-01-17
Q3 2016 107M +5.72M +5.63% Aug 31, 2016 10-K 2017-12-08
Q2 2016 107M +6.3M +6.26% May 31, 2016 10-Q 2016-07-13
Q1 2016 103M +2.02M +2.01% Feb 29, 2016 10-Q 2016-04-18
Q4 2015 102M +1.52M +1.51% Nov 30, 2015 10-Q/A 2016-04-08
Q3 2015 102M +1.25M +1.25% Aug 31, 2015 10-K 2016-12-13
Q2 2015 101M +19M +23.2% May 31, 2015 10-Q/A 2015-11-17
Q1 2015 101M +79.8M +382% Feb 28, 2015 10-Q/A 2015-11-17
Q4 2014 101M +80M +387% Nov 30, 2014 10-Q/A 2015-11-17
Q3 2014 100M +98.9M +7269% Aug 31, 2014 10-K 2016-01-07
Q2 2014 81.8M May 31, 2014 10-Q/A 2014-07-15
Q1 2014 20.9M Feb 28, 2014 10-Q 2014-04-01
Q4 2013 20.7M Nov 30, 2013 10-Q 2014-01-14
Q3 2013 1.36M Aug 31, 2013 10-K/A 2015-10-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.